Why Was Newsmax, the Right-Wing Channel, Suddenly Worth More Than U.S. Steel?
Newsmax lost $55 million in the first half of last year. But its stock surged this week as shares in the company traded on ...
Edgewise Therapeutics: Despite AF Safety Issues, EDG-7500 Advancement Presses On
Discover growth opportunities with Edgewise Therapeutics, Inc. in the hypertrophic cardiomyopathy market. Click for my EWTX ...
GSK: Under Threat From 'Double Whammy' Of Vaccine Skepticism And Pharma Tariffs
Explore how U.S. tariffs and vaccine skepticism may impact GSK plc's profitability. Click for my update as tariffs are ...
Novavax Falls But Then Recovers After WSJ Report on Vaccine's FDA Status
The vaccine is approved for emergency use. The FDA had set an April 1 deadline for a decision on whether to grant a normal, full approval, the WSJ reported. Write to [email protected] ...